Ovid Therapeutics Inc. (OVID) Social Stream
OVID THERAPEUTICS INC (OVID) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering OVID.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 5 | $7 | $4 | $5.5 | $3.1 | 77.42% |
| 2022-08-11 | 3 | $7 | $4 | $5.5 | $3.1 | 77.42% |
| 2023-08-07 | 4 | $7 | $4 | $5.5 | $3.1 | 77.42% |
| 2023-11-06 | 5 | $8 | $4 | $6.333 | $3.1 | 104.29% |
| 2023-12-21 | 6 | $11 | $4 | $7.5 | $3.1 | 141.94% |
The Trend in the Analyst Price Target
Over the past 20 months, OVID's average price target has gone up $2.
OVID reports an average of 75.42% for its upside potential over the past 40 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-14 | 4 | 7 | 2.5 | 4.750 | 2.08 | 128.37% |
| 2023-05-08 | 4 | 7 | 2.5 | 4.750 | 3.46 | 37.28% |
| 2023-08-07 | 4 | 7 | 4.0 | 5.500 | 3.26 | 68.71% |
| 2023-10-13 | 5 | 8 | 4.0 | 6.333 | 3.67 | 72.56% |
| 2023-10-20 | 5 | 8 | 4.0 | 6.333 | 3.47 | 82.51% |
OVID Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 5 | 0 | 1 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 27 months, OVID's average broker recommendation rating improved by 0.96.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for OVID as an investment opportunity.
- OVID THERAPEUTICS INC's average analyst price target is higher than 48.99% of all US stocks.
- OVID has a greater number of analysts covering the stock than 125.9% of all US stocks.
- In the context of stocks in the small market cap category, OVID THERAPEUTICS INC's variance in analysts' estimates is lower than -379.33% of them.
- OVID has a greater upside potential (average analyst target price relative to current price) than 403.83% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, ACIU, SNDX, and NEPT are the three stocks most similar to OVID THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for OVID? Use POWR Ratings for clearer insight into price direction.